The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19...
19 KB (1,436 words) - 08:53, 24 September 2024
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
5 KB (294 words) - 08:54, 24 September 2024
October 2011. "Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine". Business Insider. "SanofiPasteur.us". Sanofi Pasteur. Retrieved 2 February...
23 KB (2,049 words) - 04:08, 25 September 2024
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
202 KB (22,914 words) - 18:39, 23 September 2024
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
260 KB (22,082 words) - 05:55, 13 September 2024
Turkey The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is...
322 KB (19,558 words) - 03:33, 16 September 2024
Razi Cov Pars, Sanofi–GSK, Sinopharm CNBG, Skycovione, Soberana 02, Soberana Plus, V-01, and ZF2001. one virus-like particle vaccine: CoVLP As of June 2022[update]...
95 KB (18,965 words) - 23:35, 15 September 2024
that last point. McGrail S (15 April 2020). "Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine". PharmaNewsIntelligence. Archived from the original...
122 KB (11,033 words) - 22:07, 17 July 2024
countries, the dissemination of varied claims and perspectives regarding COVID-19 vaccines has sparked widespread public discussion. These include concerns about...
132 KB (12,898 words) - 16:08, 19 September 2024
million people and causes 160,000 deaths worldwide each year. The RSV vaccines Arexvy (GSK), Abrysvo (Pfizer), and Mresvia (Moderna) are approved for medical...
52 KB (4,072 words) - 19:18, 26 September 2024
Corbevax (redirect from Bio E COVID-19)
(around $3) per dose. The vaccine is not patented and is planned to be openly licensed under COVAX. Sanofi–GSK COVID-19 vaccine "A prospective open label...
18 KB (1,471 words) - 20:57, 3 September 2024
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
73 KB (5,473 words) - 05:56, 24 September 2024
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute...
4 KB (192 words) - 08:25, 24 September 2024
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF)...
2 KB (108 words) - 10:50, 24 September 2024
53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
156 KB (13,914 words) - 23:28, 12 August 2024
million doses of a COVID-19 vaccine developed by GSK and Sanofi. It uses a recombinant protein-based technology from Sanofi and GSK's pandemic technology...
135 KB (12,153 words) - 22:29, 28 September 2024
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden,...
141 KB (11,331 words) - 06:12, 24 September 2024
million doses of COVID-19 vaccine, 31 July 2020, retrieved 7 August 2020 Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and...
92 KB (8,810 words) - 04:11, 13 September 2024
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Patent Landscape Report COVID-19-related vaccines and therapeutics"...
3 KB (113 words) - 09:01, 24 September 2024
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
214 KB (17,080 words) - 15:51, 27 September 2024
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
15 KB (1,455 words) - 06:02, 24 September 2024
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
176 KB (13,684 words) - 05:20, 13 September 2024
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical...
5 KB (373 words) - 16:14, 26 September 2024
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
9 KB (880 words) - 06:15, 24 September 2024
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai...
4 KB (321 words) - 06:04, 24 September 2024
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
90 KB (8,588 words) - 08:11, 24 September 2024
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results...
11 KB (1,013 words) - 08:58, 24 September 2024
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In...
7 KB (668 words) - 20:53, 27 September 2023
Operation Warp Speed (redirect from Trump vaccine)
2021. Angus Liu (July 31, 2020). "Top vaccine players Sanofi, GSK win $2.1B Warp Speed funding for COVID-19 shot". FiercePharma. Archived from the original...
71 KB (5,902 words) - 06:09, 15 August 2024
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences...
15 KB (1,451 words) - 10:24, 24 September 2024